Offer - Urjas Oil for just ₹ 1
Malirid 2.5 Mg Tablet DT, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Malaria. Malirid 2.5 Mg Tablet DT also has some secondary and off-label uses. These are listed below.
The correct dosage of Malirid 2.5 Mg Tablet DT depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Malirid 2.5 Mg Tablet DT include Abdominal Pain. Some other side effects of Malirid 2.5 Mg Tablet DT have been listed ahead. Usually, these side effects of Malirid 2.5 Mg Tablet DT go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Malirid 2.5 Mg Tablet DT is Moderate for pregnant women and Moderate for women who are breastfeeding. It is important to know if Malirid 2.5 Mg Tablet DT has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Malirid 2.5 Mg Tablet DT related warnings section.
Other conditions have been mentioned below in the Malirid 2.5 Mg Tablet DT contraindications section.
Additionally, Malirid 2.5 Mg Tablet DT may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Malirid 2.5 Mg Tablet DT, it is important to know that it is not safe while driving, and is not habit-forming.
Malirid 2.5 Mg Tablet DT is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Malirid 2.5 Mg Tablet DT safe for pregnant women?
Malirid may have some side effects during pregnancy. Pregnant women should discontinue the use of Malirid, and talk to their doctor, if they notice any discomfort.
Is the use of Malirid 2.5 Mg Tablet DT safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Malirid. Immediately discontinue Malirid if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Malirid 2.5 Mg Tablet DT on the Kidneys?
Using Malirid does not have any harmful effects on kidneys.
What is the effect of Malirid 2.5 Mg Tablet DT on the Liver?
Side effects of Malirid rarely affect the liver.
What is the effect of Malirid 2.5 Mg Tablet DT on the Heart?
Malirid may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Malirid 2.5 Mg Tablet DT unless your doctor advises you to do so -
Is this Malirid 2.5 Mg Tablet DT habit forming or addictive?
Malirid 2.5 Mg Tablet DT is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Malirid 2.5 Mg Tablet DT you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Malirid 2.5 Mg Tablet DT only on doctor's advice.
Is it able to treat mental disorders?
Malirid 2.5 Mg Tablet DT is unable to treat or cure mental disorders.
Interaction between Food and Malirid 2.5 Mg Tablet DT
Taking Malirid 2.5 Mg Tablet DT with food does not cause any problems.
Interaction between Alcohol and Malirid 2.5 Mg Tablet DT
Consuming Malirid 2.5 Mg Tablet DT with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Primaquine phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 828